Lastly, CX3CR1 expression was low among all CD4+ T-cell subsets except CD4+ Temra cells, where CX3CR1 expression was enriched in the blood and significantly lower in glioblastoma (Figure 3I). This evidence concerns the gene CD4 and glioblastoma.